QbTest

The Sussex Partnership NHS Foundation Trust is in the process of awarding a contract for the provision of QbTest, a health service related specifically to a unique medical device used to objectively assess Hyperactivity, Inattention, and Impulsivity in youths. This tender falls under the industry category of Health Services (CPV: 85100000) and operates within the UK region UKJ2. Although the contract has not been formally awarded, this intention to award marks the beginning of a standstill period wherein representations can be made.

The procurement process is being conducted through a limited procurement method, specifically a direct award under the Provider Selection Regime (PSR), which commenced on 2nd September 2025 and will conclude by 1st September 2027. The detailed process excludes a prior publication of a call for competition, as dictated by the Health Care Services (Provider Selection Regime) Regulations 2023. The main procurement category is service, denoting emphasis on operational delivery over goods or works.

This tender presents significant business opportunities, particularly for SMEs with expertise in health technology and medical device provision. As QBTech Ltd is currently the sole accepted provider for QbTest, there is an opportunity for other health tech providers and innovators to seek approval for their devices or services to expand into this niche market. Given that QbTest is the only NICE-approved device available for such assessments, other businesses aiming at growth in the health services sector may consider aligning their offerings to meet regulatory standards and potentially widen the scope of authorised services.

This contract could cater effectively to businesses that have the infrastructure to collaborate with public health institutions, focusing on enhancing pediatric care and mental health assessment reliability.